Evaluation of Visual Outcomes, Complications, and Neuroadaptation Following Bilateral Implantation of enVista Envy Trifocal Intraocular Lenses
A legfontosabb adatok
- Ki végzi
- Pomeranian Medical University Szczecin
- Hol
- Lengyelország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 20 fő, tervezett
- Kezdés
- 2026. febr. 1.
- Várható befejezés
- 2029. febr.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- cataract surgery
- A regiszteradat frissítve
- 2026. július 10.
Ki vehet részt
- Életkor
- 50 év – 75 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 10 feltétel megnézéseKevesebb
Ki vehet részt
- Bilateral cataract or refractive lens exchange candidates
- Presbyopia and/or hyperopia
- Preoperative corneal astigmatism less than 1.00 diopter (D)
- Absence of ocular diseases other than cataract
- High motivation to achieve spectacle independence
- Patients willing to accept the possibility of mild photic phenomena, such as glare and halos
Ki nem vehet részt
- Ocular Conditions:; Glaucoma; Amblyopia; Macular diseases (including macular degeneration and other macular pathology); Angle kappa greater than 0.5 mm; Dry eye disease; Corneal disorders; Pupil abnormalities; Irregular astigmatism; Ocular motility disorders or strabismus; Pupil diameter < 2.5 mm under photopic conditions or > 6.0 mm under mesopic conditions; Abnormalities of the capsular bag or zonular apparatus, including pseudoexfoliation syndrome (PEX)
- Psychological and Personality Factors:; Patients with psychiatric disorders that may interfere with study participation or outcome assessment; Patients dissatisfied with progressive addition lenses (progressive spectacles); Patients with dyslexia or a history of stroke; Type A personality traits (perfectionists)
- Patients will also be excluded if the calculated IOL power falls outside the available range of +6.00 D to +34.00 D or if they have a history of laser vision correction surgery
- Lifestyle Factors:; Patients with unrealistic expectations regarding postoperative visual outcomes; Individuals whose professions require highly precise visual performance, such as pilots, professional drivers, architects, or similar occupations; Patients satisfied with using spectacles for near vision; Age greater than 75 years (due to potential difficulties with neuroadaptation to new visual conditions)
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 50 és 75 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Lengyelország.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The enVista Envy intraocular lens (IOL) manufactured by Bausch + Lomb is a new multifocal intraocular lens based on diffractive optics. It was registered with the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in September 2025. The lens also bears the CE mark, indicating that it is approved for marketing and use within the European Union.
A teljes eredeti leírásKevesebb
Its innovative design is based on a smooth, continuous transition between diffractive rings, allowing patients to achieve excellent visual quality at far, intermediate, and near distances while reducing the incidence and severity of unwanted photic phenomena such as glare and halos. Thanks to this technology, patients may achieve better uncorrected visual acuity, reduced dependence on spectacles, and faster neuroadaptation.
The Second Department of Ophthalmology is the first center in Poland to be offered participation in a clinical study evaluating the safety and effectiveness of the enVista Envy IOL. The planned study will provide the first clinical experience with this lens in Poland and contribute to expanding knowledge regarding modern intraocular lens technologies.
Twenty patients will be selected according to predefined inclusion and exclusion criteria. Preoperative assessment will include a comprehensive ophthalmic examination and IOL power calculation. Cataract surgery will be performed using bimanual MICS (Micro-Incision Cataract Surgery) phacoemulsification. Surgery in the fellow eye will be performed one month after the first procedure.
Before surgery and during follow-up visits at 1, 3, and 6 months postoperatively, the following assessments will be performed: routine ophthalmic examination, intraocular pressure (IOP) measurement, visual evoked potentials (VEP), monocular and binocular uncorrected distance visual acuity (UDVA), distance best-corrected visual acuity (DBCVA) at 4 meters, intermediate visual acuity (66 cm) and near visual acuity (40 cm), both corrected and uncorrected, monocularly and binocularly (logMAR charts), binocular contrast sensitivity testing, and defocus curve assessment.
Intraoperative and postoperative complications, quality of vision (using the standardized Quality of Vision Questionnaire [QoV] and the Near Activity Vision Questionnaire [NAVQ]), speed of neuroadaptation, spectacle independence, and the occurrence of photic phenomena such as glare and halos will also be analyzed.
A vizsgálat csoportja
- 20 patients (40 eyes)A vizsgált kezelés
Patients who meet all inclusion criteria and none of the exclusion criteria.
Kezelés: cataract surgery
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Kérdések a feltételekről
- Forrás: NCT07696130: ki vehet részt
- A regiszteradat frissítve
- 2026. július 10.